Abstract
Follicular lymphoma (FL) is a kind of indolent non-Hodgkin lymphoma deriving from follicle germinal center. Relapsed and refractory FL usually requires multiline treatments. With the great advance of novel drugs and a large number of clinical trials, the treatment model of FL has been changing continually. High dose therapy combined with hematopoietic stem cell transplant could provide preferable remissions for FL patients. Meanwhile, as more and more clinical trials have made great progress, novel drugs including inhibitors of PI3K, programmed death-1 (PD-1) or lenalidomide and antibody radionuclide conjugate have brought an increasing options for FL treatment. Key words: Lymphoma, follicular; Therapy; Progress
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
